A Pilot RCT on the Effect of ExAT on Teacher Burnout and Stress
Launched by CHINESE UNIVERSITY OF HONG KONG · Nov 24, 2022
Trial Information
Current as of January 17, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how Expressive Art Therapy (ExAT) might help reduce feelings of burnout and stress among teachers in Hong Kong. The trial will involve 90 primary and secondary school teachers who will be randomly assigned to either participate in the therapy sessions or join a waitlist group. If in the ExAT group, teachers will attend workshops for two hours a day over two weeks, engaging in activities like body movement, writing, and creating art to help them relax and connect with their emotions. The waitlist group won’t receive the therapy during the study but will get helpful art materials afterward.
To be eligible, participants need to be at least 18 years old, live in Hong Kong, and be qualified teachers. They should also be able to read Chinese. Those currently receiving psychological treatment for stress or burnout, or who have recently changed their mood-related medications, will not be eligible to participate. Throughout the study, all participants will complete questionnaires to track their stress, burnout, and overall well-being, both before and after the therapy sessions, and again four weeks later. This trial aims to see if this creative approach can effectively help teachers manage their stress and improve their mental health.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Hong Kong residents aged \>/=18
- • 2. Able to read Chinese (verbal expression in Chinese or English)
- • 3. With qualified teaching cert. (degree holder)
- • 4. Willing to provide informed consent and comply with the trial protocol
- • 5. Teacher work in primary or secondary school in Hong Kong
- Exclusion Criteria:
- • 1. Current involvement in psychological treatment program for stress and / or burnout reduction
- • 2. A change in psychotropic drugs or over-the-counter medications that target mood within 2 weeks before the baseline assessment
- • 3. A Patient Health Questionnair-9 (PHQ-9) item 9 score \> 2 indicating a serious level of suicidal risk
Trial Officials
Fiona YY Ho, Ph.D
Principal Investigator
Chinese University of Hong Kong
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials